Viewing data from:

HYDROXOCOBALAMIN

ANDA

HYDROXOCOBALAMIN | A085998 | ACTAVIS LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$0.8144

per ml

Lowest NADAC/Unit

$0.8144

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00591288830HYDROXOCOBALAMIN 1,000 MCG/ML	$0.8144	ML	Generic	—	2026-03-18

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain5 active DMFs1 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

EUROAPI FRANCEHYDROXOCOBALAMIN ACETATE PH.EUR.,JP,PYROGEN-FREE

DMF 161522002

EUROAPI FRANCEHYDROXOCOBALAMIN

DMF 182162005

HEBEI HUARONG PHARMACEUTICAL CO LTDHYDROXOCOBALAMIN ACETATE

DMF 272292013

SUPRIYA LIFESCIENCE LTDHYDROXOCOBALAMIN USP

DMF 371682022

HEBEI HUARONG PHARMACEUTICAL CO LTDHYDROXOCOBALAMIN ACETATE

DMF 386382023

HOECHST MARION ROUSSEL SAInactiveHYDROXOCOBALAMIN BASE

DMF 91001991

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 1MG/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.